Equinix — Oct 30, 2024 release
Fiscal 2024 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001628280-24-044328
Showing in the filing
AFFO growth (as-reported)
“11 - 12%”
Period
FY2024
Measure
Company-defined measure
Source
Prose
All guidance in this release · 19
Adjusted EBITDA margin for FY2024
“47%”
AFFO growth (normalized and constant currency) for FY2024
“11 - 13%”
AFFO per share growth (normalized and consta… for FY2024
“9 - 10%”
Revenues for Q4 FY2024
“$2.262 and $2.302 billion”
Revenues growth (as-reported) for Q4 FY2024
“3 - 5%”
Revenues growth (normalized and constant cur… for Q4 FY2024
“2 - 4%”
Adjusted EBITDA for Q4 FY2024
“$1.010 and $1.050 billion”
Recurring capital expenditures for Q4 FY2024
“$94 and $114 million”
Total revenues for FY2024
“$8.748 and $8.788 billion”
Total revenues growth (as-reported) for FY2024
“approximately 7%”
Total revenues growth (normalized and consta… for FY2024
“approximately 7 - 8%”
Adjusted EBITDA for FY2024
“$4.086 and $4.126 billion”
AFFO for FY2024
“$3.338 and $3.378 billion”
AFFO growth (as-reported) for FY2024
“11 - 12%”
AFFO per share for FY2024
“$34.81 and $35.22”
AFFO per share growth (as-reported) for FY2024
“8 - 10%”
Total capital expenditures for FY2024
“$2.850 and $3.100 billion”
Non-recurring capital expenditures (includin… for FY2024
“$2.620 and $2.850 billion”
Recurring capital expenditures for FY2024
“$230 and $250 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
This $10 million increase over previously issued guidance is due to a positive foreign currency benefit when compared to prior guidance rates. AFFO is expected to range between $3.338 and $3.378 billion, an as-reported increase of 11 - 12% over the previous year, or a normalized and constant currency increase of 11 - 13%. This $18 million increase over the previously issued guidance is due to $15 million from better-than-expected operating performance and a $3 million positive foreign currency benefit when compared to prior guidance rates. AFFO per share is expected to range between $34.81 and $35.22, an as-reported increase of 8 - 10% over the previous year, or a normalized and constant currency increase of 9 - 10%. Total capital expenditures are expected to range between $2.850 and $3.100 billion. Non-recurring capital expenditures, including xScale-related capital expenditures, are expected to range between $2.620 and $2.850 billion, and recurring capital expenditures are expected to range between $230 and $250 million. The U.S. dollar exchange rates used for 2024 guidance, taking into consideration the impact of our current foreign currency hedges, have been updated to $1.11 to the Euro, $1.28 to the Pound, S$1.29 to the U.S. Dollar, ¥144 to the U.S. Dollar, A$1.45 to the U.S. Dollar, HK$7.77 to the U.S. Dollar, R$5.46 to the U.S. Dollar and C$1.35 to the U.S. Dollar. The Q3 2024 global revenue breakdown by curr
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.